Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Adelmidrol
Cat. No.:
0225LY-0859
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Adelmidrol is an ethanolamide derivative of azelaic acid that possesses significant anti-inflammatory properties.
Synonym:
1675-66-7; N,N'-bis(2-hydroxyethyl)nonanediamide; AdelMitrol; Adelmidrol [INN]; N1,N9-Bis(2-hydroxyethyl)nonanediamide; adelmidrolum; Nonanediamide, N,N'-bis(2-hydroxyethyl)-
CAS No.:
1675-66-7
Compound CID:
176874
Formula:
C13H26N2O4
Formula Weight:
274.36
Specification
Relative Density:
1.097 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Adelmidrol can be used in dermatology research to study the local anti-inflammatory effects of palmitoylethanolamide analogs.
Library Information
Target:
NF-κB; PPAR; COX
Receptor:
NF-κB; PPAR; COX
Pathways:
DNA damage/DNA repair; Immunology/Inflammation; Metabolism; Neuronal signaling; NF-κB
Plate Number:
AOCL-12
Plate Location:
a8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
55 mg/mL; 200.47 mM
